[go: up one dir, main page]

US2986564A - Pyrrole compounds - Google Patents

Pyrrole compounds Download PDF

Info

Publication number
US2986564A
US2986564A US794507A US79450759A US2986564A US 2986564 A US2986564 A US 2986564A US 794507 A US794507 A US 794507A US 79450759 A US79450759 A US 79450759A US 2986564 A US2986564 A US 2986564A
Authority
US
United States
Prior art keywords
pyrrole
alk
low
acid addition
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US794507A
Inventor
Rips Richard
Buu Hoi Nguyen Phuc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US794507A priority Critical patent/US2986564A/en
Application granted granted Critical
Publication of US2986564A publication Critical patent/US2986564A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Definitions

  • R is a member of the group consisting of methyl and phenyl.
  • R is a member of the group consisting of methyl and phenyl.
  • X is a member of the group consisting of S, O,
  • lower alkyl radicals need not be identical; the term lower alkyl is intended to include both the straight and branched chain C -C alkyl radicals. They may, for example, be methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl, heptyl, octyl, isooctyl, etc.
  • the compounds to which this invention relate are useful because of their various pharmacological properties. Notably, they are active as antispasmodics (particularly musculotropic), analgesics, tranquilizers, anesthetics and hypotensives. Thus, for example, neutral aqueous solutions of these compounds can be administered intramuscularly or intraperitoneally. Since the amino compounds of the instant invention are basic in character they can, if desired, be utilized in the form of their acid addition salts, notably the hydrochloride, or of their quaternary ammonium salts.
  • hydrochlorides of l-(2-fi-diethyl-aminoetheroxy phenyl) Z-methyI-S-phenyl pyrrole, and -5 methyl pyrrole have exhibited many times the activity of papaverine.
  • amino pyrroles where X is ortho to the pyrrole ring seem to have a higher activity than the corresponding meta or para positioned compounds.
  • EXAMPLE II 1-(Z-fi-diethylamino'ethoxyphenyl) -2-merhyl-5-phenyl pyrrole (a) Condensation of phenacylacetone on o-aminophen- EXAMPLE III 1-(2-fi-diethylam inoethoxyphenyl) -2,5-diphenylpyrrole (a) Condensation of dibenzoylethane with o-aminophenol according to the procedure of Example Ia affords 1-(2-hydroxyphenyl)-2,5-diphenylpyrrole, B.P. 240 C./ 11 mm. M.P. 183 C.
  • Example Ia In the same manner as in Example Ia, acetonylacetone is condensed with p-aminophenol forming the analogous -p-hydroxylated compound, B.P. 178 C./ 12 mm., whose diethylaminoethylic etheroxide, prepared as described in Example Ib above, has B.P. 200 C./l3 mm., n 1.5501.
  • EXAMPLE IV 1 -(2-d1ethylamin0ethi0phenyl)-2,5-dimethylpyrr0le 4
  • EXAMPLE v Diethylam'inoethyl ester of Z-(ZJ-dimethyIpyfryl) benzoic acid (a) Condensation of acetonylacetone with o-aminobenzoic acid according to the procedure of Example Ia afiords 2-(2,5-dimethylpyr'ryl) benzoic acid, B.P. 195 C./ 14 mm.
  • R and R are each members selected from the group consisting of methyl and phenyl; where X is a member selected from the group consisting of 0, S and (b) non-toxic acid addition salts thereof; and (c) nontoxic benzyl quaternary ammonium salts thereof.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Description

United States Patent PYRROLE COMPOUNDS Richard Rips, 21 rue de la Tour dAuvergne, Paris,
France, and 'Ho'l' Nguyen Phuc Buu, Radium Institute, 26 rue dUlm, Paris, France N0 Drawing. Filed Feb. 20, 1959, Ser. No. 794,507
11 Claims. (Cl. 260-313) the formula X-Low. Alk.N
Low. Alk- Low. Alk.
where R is a member of the group consisting of methyl and phenyl.
R is a member of the group consisting of methyl and phenyl.
X is a member of the group consisting of S, O,
The several lower alkyl radicals need not be identical; the term lower alkyl is intended to include both the straight and branched chain C -C alkyl radicals. They may, for example, be methyl, ethyl, propyl, isopropyl, butyl, isobutyl, pentyl, hexyl, heptyl, octyl, isooctyl, etc.
The compounds to which this invention relate are useful because of their various pharmacological properties. Notably, they are active as antispasmodics (particularly musculotropic), analgesics, tranquilizers, anesthetics and hypotensives. Thus, for example, neutral aqueous solutions of these compounds can be administered intramuscularly or intraperitoneally. Since the amino compounds of the instant invention are basic in character they can, if desired, be utilized in the form of their acid addition salts, notably the hydrochloride, or of their quaternary ammonium salts. Thus, the hydrochlorides of l-(2-fi-diethyl-aminoetheroxy phenyl) Z-methyI-S-phenyl pyrrole, and -5 methyl pyrrole have exhibited many times the activity of papaverine. In general the amino pyrroles where X is ortho to the pyrrole ring seem to have a higher activity than the corresponding meta or para positioned compounds.
Synthesis of the aminoetheroxides, aminothioethers and aminoesters of the instant invention is accomplished in two principal steps in the following manner.
(a) Condensation of a gamma diketone with an arcmatic amine bearing ortho, meta or para, a phenolic, thiophenolic or carboxylic group. The condensation with a phenol, for example, results in a hydroxy-aryl l-pyrrole com-pound.
(b) Then reaction of the alkali metal salt of the condensation product with an aminoalkyl chloride which is di-substituted on the amino group with the desired C H radicals.
By and large the reaction sequence is as follows:
Bi L l O a Low. Alk.
XNa +OlL0w. Alk.-N\ Low. Alk.
X-Low. Alk.-N
Low. Alkz LOW. Alk.
niques for quaternizing tertiary amines by, for example,- 1
reaction with benzyl chloride.
Only the non-toxic acid addition and quaternary ammonium salts are, of course, administrable as pharmaceuticals.
The following examples illustrate the detailed practice of the instant process and the novel compounds prepared thereby.
EXAMPLE I Synthesis of 1-(2-B-diethylam inoethoxyph enyl) -2,5-dimethyl-pyrrole (a) In a distillation flask of appropriate size, an equimolar mixture of o-aminophenol and acetonylacetone is gently brought to the boil, elimination of water vapor occurs, and after approximately two hours of boiling, the water has been entirely distilled off. The I-(Z-hydroxyphenyl)-2,5-dimethylpyrrole formed thereby is then distilled in vacuo. The yield, regardless of the quantities used to begin with, is always of the order of B.P. 149 C./ 18 mm., straw-colored liquid, crystallizing spontaneously in the receptor flask in colorless needles, M.P., 102 C.
Analysia-Calcd. .for C H NO: C, 76.9; H, 7.0; N, 7.9. Found: C, 76.8; H, 7.0; N, 7.5.
(b) One mole of the foregoing compound is dissolved in ethyl alcohol; one mo1e+l0% in excess is added of an alcoholic solution of caustic soda (or potash); the mixture is boiled for a few minutes to accomplish the formation of the alkali salt, then left to cool. One mole+10% excess of diethylaminoethyl chloride is then added, the mixture left to react 10 minutes, then boiled for one hour, then poured into water, extracted with chloroform, washed thoroughly with water, the solvent distilled, and the residue fractionated in vacuo. B.P. 189-490 C./ 16 mm., 71 1.5430. Yield: 90%.
3 AnaIysis.-Ca1cd. for C H N O: C, 75.5; H, 9.1; N, 9.8. Found: C, 75.5; H, 9.1; N, 9.6. Hydrochloride, M.P. 188 C.
EXAMPLE II 1-(Z-fi-diethylamino'ethoxyphenyl) -2-merhyl-5-phenyl pyrrole (a) Condensation of phenacylacetone on o-aminophen- EXAMPLE III 1-(2-fi-diethylam inoethoxyphenyl) -2,5-diphenylpyrrole (a) Condensation of dibenzoylethane with o-aminophenol according to the procedure of Example Ia affords 1-(2-hydroxyphenyl)-2,5-diphenylpyrrole, B.P. 240 C./ 11 mm. M.P. 183 C.
(b) The diethylaminoetheroxide of the foregoing compound is obtained in the same way as for Examples I and II; it boils at 279 C./22 mm.; hydrochloride, M.P. 175 C. 1
Analysis.-Calcd.: N, 12.97. Found: N, 12.94.
In the same manner as in Example Ia, acetonylacetone is condensed with p-aminophenol forming the analogous -p-hydroxylated compound, B.P. 178 C./ 12 mm., whose diethylaminoethylic etheroxide, prepared as described in Example Ib above, has B.P. 200 C./l3 mm., n 1.5501.
Other substituted chains have been prepared in the same manner. Starting with the I-(Z-hydroxyphenyD-Z, S-dimethylpyrrole of Example Ia there has been prepared the:
Dimethylaminopropylic etheroxide, B.P. 174-176 C./ 17 mm., 21 1.5551; hydrochloride, M.P. 180 C. Dimethylaminoisopropylie etheroxide, B.P. 177
n 1.5536; hydrochloride, M.P. 151152 C. Diisopropylaminoethylic etheroxide, B.P. 185 C./15
mm., n 1.6079; hydrochloride, M.P. 142.5 C. Dimethylaminoethyl'ic etheroxide, B.P. 176178 16 mm., n 1.5585; hydrochloride, M.P. 173 C.
EXAMPLE IV 1 -(2-d1ethylamin0ethi0phenyl)-2,5-dimethylpyrr0le 4 EXAMPLE v Diethylam'inoethyl ester of Z-(ZJ-dimethyIpyfryl) benzoic acid (a) Condensation of acetonylacetone with o-aminobenzoic acid according to the procedure of Example Ia afiords 2-(2,5-dimethylpyr'ryl) benzoic acid, B.P. 195 C./ 14 mm.
(b) Its dimethylaminoethyl ester, formed by condensation of 'its sodium salt with diethylaminoethyl chloride according to the procedure of Example Ib boils at 217 C./17 mm., 12 1.5432; hydrochloride, M.P. 121 C.
What is claimed is:
1. A compound selected from the group consisting of (a) l-substituted pyrroles having the formula i I R- N R I Low. Alk.
X-LOW. Alk.-N
Low. Allr.
where R and R are each members selected from the group consisting of methyl and phenyl; where X is a member selected from the group consisting of 0, S and (b) non-toxic acid addition salts thereof; and (c) nontoxic benzyl quaternary ammonium salts thereof.
2. A non-toxic acid addition salt of 1-(2-B-diethyl aminoethoxyphenyl)-2 methyl-S phenyl pyrrole.
3. A non-toxic acid addition salt of I-(Z-fl-diethylaminoethoxyphenyl) -2,5-dimethyl pyrrole.
4. A non-toxic acid addition salt of 1-(2-fl-diethylaminoethoxyphenyl)-2,5-diphenyl pyrrole.
5. A non-toxic acid addition salt of 1-(2-fi-diisopropyl aminoethoxyphenyl)-2,5-dimethyl pyrrole.
6. A non-toxic acid addition salt of the diethylamino ethy-lthioether of l-(2mercaptophenyl)-2,5-dimethyl pyrrole.
7. 1-(2-5 diethylaminoethoxyphenyl) 2 methyl 5 pheny pyrrole.
8. 1 (2 B diethylaminoethoxyphenyl)-2,5-dimethyi pyrrole.
9. 1 (2 B diethylaminoethoxyphenyl)-2,5-diphenyl pyrrole.
10. 1 (2 ,8 diisopropylaminoethoxyphenyl) 2,5 dimethyl pyrrole.
11. The diethylaminoethylthioether of 1-(2-mercaptophenyl)-2,5-dimethyl pyrrole.
References Cited in the file of this patent UNITED STATES PATENTS 2,410,783 Hardman Nov. 5, 1946 FOREIGN PATENTS 271,776 Switzerland Feb. 16, 1951

Claims (2)

1. A COMPOUND SELECTED FROM THE GROUP CONSISTING OF (A) 1-SUBSTITUTED PYRROLES HAVING THE FORMULA
6. A NON-TOXIC ACID ADDITION SALT OF THE DIETHYLAMINO ETHYLTHIOETHER OF 1-(2-MERCAPTOPHENYL)-2,5-DIMETHYL PYRROLE.
US794507A 1959-02-20 1959-02-20 Pyrrole compounds Expired - Lifetime US2986564A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US794507A US2986564A (en) 1959-02-20 1959-02-20 Pyrrole compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US794507A US2986564A (en) 1959-02-20 1959-02-20 Pyrrole compounds

Publications (1)

Publication Number Publication Date
US2986564A true US2986564A (en) 1961-05-30

Family

ID=25162825

Family Applications (1)

Application Number Title Priority Date Filing Date
US794507A Expired - Lifetime US2986564A (en) 1959-02-20 1959-02-20 Pyrrole compounds

Country Status (1)

Country Link
US (1) US2986564A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196073A (en) * 1961-03-16 1965-07-20 Dow Chemical Co Method of tranquilizing with 1, 2-dihydroxy propane
US3225061A (en) * 1962-10-17 1965-12-21 Nat Distillers Chem Corp Derivatives of 2,5-diarylpyrrole
FR2007553A1 (en) * 1968-04-29 1970-01-09 Geigy Ag J R
US3532712A (en) * 1967-09-29 1970-10-06 Aldrich Chem Co Inc N'-cyclopropyl ethylenediamine derivatives
FR2551063A1 (en) * 1983-08-22 1985-03-01 Inst Nat Sante Rech Med New 2,5-dimethylpyrroles, process for preparing them and their therapeutic use
DK153837B (en) * 1973-03-09 1988-09-12 Ciba Geigy Ag METHOD OF ANALOGY FOR THE PREPARATION OF PYRROL DERIVATIVES OR THEIR THERAPEUTICALLY APPLIED SALTS
US4792568A (en) * 1986-04-14 1988-12-20 Rorer Pharmaceutical Corporation Aryl pyrroles as useful antiallergy compounds
US5096919A (en) * 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
WO2004026828A1 (en) * 2002-09-20 2004-04-01 Lupin Limited Pyrrole derivatives as antimycobacterial compounds
WO2016061538A1 (en) * 2014-10-16 2016-04-21 The Board Of Trustees Of The Leland Stanford Junior University Novel methods, compounds, and compositions for anesthesia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410783A (en) * 1943-02-26 1946-11-05 Wingfoot Corp Age resisters
CH271776A (en) * 1949-01-06 1950-11-15 Ag J R Geigy Process for the preparation of a basic ether of an ortho-substituted phenol.

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2410783A (en) * 1943-02-26 1946-11-05 Wingfoot Corp Age resisters
CH271776A (en) * 1949-01-06 1950-11-15 Ag J R Geigy Process for the preparation of a basic ether of an ortho-substituted phenol.

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196073A (en) * 1961-03-16 1965-07-20 Dow Chemical Co Method of tranquilizing with 1, 2-dihydroxy propane
US3225061A (en) * 1962-10-17 1965-12-21 Nat Distillers Chem Corp Derivatives of 2,5-diarylpyrrole
US3532712A (en) * 1967-09-29 1970-10-06 Aldrich Chem Co Inc N'-cyclopropyl ethylenediamine derivatives
FR2007553A1 (en) * 1968-04-29 1970-01-09 Geigy Ag J R
DK153837B (en) * 1973-03-09 1988-09-12 Ciba Geigy Ag METHOD OF ANALOGY FOR THE PREPARATION OF PYRROL DERIVATIVES OR THEIR THERAPEUTICALLY APPLIED SALTS
FR2551063A1 (en) * 1983-08-22 1985-03-01 Inst Nat Sante Rech Med New 2,5-dimethylpyrroles, process for preparing them and their therapeutic use
US4792568A (en) * 1986-04-14 1988-12-20 Rorer Pharmaceutical Corporation Aryl pyrroles as useful antiallergy compounds
US5096919A (en) * 1989-01-05 1992-03-17 Ciba-Geigy Corporation Pyrrolylphenyl-substituted hydroxamic acid derivatives
WO2004026828A1 (en) * 2002-09-20 2004-04-01 Lupin Limited Pyrrole derivatives as antimycobacterial compounds
US20050107370A1 (en) * 2002-09-20 2005-05-19 Arora Sudershan K. Pyrrole derivatives as antimycobacterial compounds
US20080242676A1 (en) * 2002-09-20 2008-10-02 Lupin Limited Pyrrole derivatives as antimycobacterial compounds
AP1979A (en) * 2002-09-20 2009-03-20 Lupin Ltd Pyrrole derivatives as antimycobacterial compounds
AU2002343200B2 (en) * 2002-09-20 2009-08-13 Lupin Limited Pyrrole derivatives as antimycobacterial compounds
EA012461B1 (en) * 2002-09-20 2009-10-30 Люпин Лимитед Compounds having antimycobacterial activity
US7691837B2 (en) 2002-09-20 2010-04-06 Lupin Limited Pyrrole derivatives as antimycobacterial compounds
US7763602B2 (en) 2002-09-20 2010-07-27 Lupin Limited Pyrrole derivatives as antimycobacterial compounds
WO2016061538A1 (en) * 2014-10-16 2016-04-21 The Board Of Trustees Of The Leland Stanford Junior University Novel methods, compounds, and compositions for anesthesia
US10513494B2 (en) 2014-10-16 2019-12-24 The Board Of Trustees Of The Leland Stanford Junior University Methods, compounds, and compositions for anesthesia

Similar Documents

Publication Publication Date Title
US2986564A (en) Pyrrole compounds
US2220834A (en) Phenolic triamines
Pyman CCCXCVII.—The tautomerism of amidines. Part III. The alkylation of open-chain amidines (continued)
US3254120A (en) N-(tertiaryaminoalkoxy-benzoyl) anilides
US2819305A (en) Aminoalkylamides of butoxybenzoic acid
DE1493454C3 (en) 1 -Aryloxy ^ -hydroxy-S-isopropylaminopropane and their salts, as well as their production and pharmaceuticals based thereon
US3213140A (en) 2-phenyl-4, 6-dichlorophenoxyethylamine and salts thereof
US2822391A (en) Conhj
US2879294A (en) 1, 1-diaryl-2-aminoalkanols
US2497394A (en) Alkylaminoalkyl benzoates
JPS598260B2 (en) 10-Amino-9,10-dihydrophenanthrene derivative and method for producing the same
JPS5982365A (en) Novel racemic resolution keto compound and manufacture
Exner et al. Reactive Nitrile Groups. I. The Reaction of α, ι-Dinitriles with Aqueous Amines1
US2016480A (en) Perhydrocarbazyl compounds of the pyridine and quinoline series
US2519325A (en) Antihistamine compounds
US3058986A (en) N-ammoalkyl-x-phenyl-x-lower alkyl-z-
US2881172A (en) Chemical compounds
US3576819A (en) Esters of alpha-(1-substituted-3-pyrrolidinyl)-alpha-phenyl acetic acid
US2339914A (en) Chemical compound
JPS6015616B2 (en) Method for producing N-2-(pyrrolidinylmethyl)-substituted benzamide derivative or salts thereof
NO135092B (en)
US2674615A (en) 1-arylcycloalkane 1-thiocar-boxylates
Gump et al. Adrenergic Blocking Agents. II. N-(2-Chloroethyl)-N-(2-phenoxyethyl)-amine Hydrochlorides1
Newbery et al. 139. Attempts to find new chemotherapeutic amidines. Part VIII. Some aliphatic monoamidines
US4161532A (en) N-(1'-ethyl-2'-oxo-5'-pyrrolidinylmethyl) benzamide compounds and derivatives, method of preparation and pharmaceutical preparations